Seebri and Neupogen drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Seebri (glycopyrrolate) and Neupogen (filgrastim). Common drug interactions include face oedema among males.
The phase IV clinical study analyzes what interactions people have when they take Seebri and Neupogen. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.
What is Seebri?
Seebri has active ingredients of glycopyrrolate. eHealthMe is studying from 2,618 Seebri users. Check the latest studies of Seebri.
What is Neupogen?
Neupogen has active ingredients of filgrastim. It is often used in agranulocytosis. eHealthMe is studying from 23,898 Neupogen users. Check the latest studies of Neupogen.
11 people who take Seebri and Neupogen together, and have interactions are studied.
What are the common drug interactions of Seebri and Neupogen, by gender? *:
female:
n/a
male:
- Face oedema (swelling of face)
- Pruritus (severe itching of the skin)
- Pyrexia (fever)
- Rash generalised (rash on most of body parts)
- Prostate cancer metastatic
- Rash
What are the common drug interactions of Seebri and Neupogen, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
n/a
60+:
- Face oedema (swelling of face)
- Pruritus (severe itching of the skin)
- Pyrexia (fever)
- Rash generalised (rash on most of body parts)
- Rash
What are the existing conditions these people have? *
- Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 10 people, 90.91%
- Prostate Cancer: 1 person, 9.09%
* Approximation only. Some reports may have incomplete information.
Do you take Seebri and Neupogen?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Seebri and Neupogen:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Seebri:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Neupogen:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Seebri and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Neupogen and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- D'souza S, Gowler V, "Glycopyrrolate‐induced respiratory arrest: an unusual side effect", Acta Anaesthesiologica Scandinavica, 2015 Mar .
- D'souza S, Gowler V, "Glycopyrrolate‐induced respiratory arrest: an unusual side effect", Acta Anaesthesiologica Scandinavica, 2015 Mar .
How the study uses the data?
The study uses data from the FDA. It is based on glycopyrrolate and filgrastim (the active ingredients of Seebri and Neupogen, respectively), and Seebri and Neupogen (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Vascepa and Plaquenil - 2 seconds ago
- Drug interactions of Motrin and Tamsulosin - 4 seconds ago
- Could Fluconazole cause Post Procedural Complication? - 13 seconds ago
- Could Fluconazole cause Hip Joint Replacement? - 16 seconds ago
- Could Flovent cause Blood Pressure Abnormal? - 23 seconds ago
- Drug interactions of Varenicline Tartrate and Dupixent - 25 seconds ago
- Could Omeprazole cause Pressure Ulcer? - 34 seconds ago
- Drug interactions of Gatifloxacin and Percocet - 37 seconds ago
- Could Meperidine Hydrochloride cause Pain In Extremity? - 39 seconds ago
- Dizziness and Libido Decreased - 40 seconds ago